← Devices & Neurotechnology
Details checkedStrong evidenceCheckedcompany
MED-EL SYNCHRONY ABI
Also known as: MED-EL Auditory Brainstem Implant, SYNCHRONY ABI, ABI
MED-EL
Company
MED-EL
Program Type
Device
Modality
Cochlear/Auditory Implant
Stage
Marketed
Status
Marketed
Target Gene
—
Route / Mode
Implantable device
Confidence
86%
Status Confidence
Status confirmed
Evidence Strength
Strong evidence
Last Reviewed
2026-05-31
Geography
Global; market-specific regulatory availability needs verification
Population
profound
Trial IDs
0
Mechanism
Implantable auditory brainstem implant that bypasses the auditory nerve and directly stimulates the cochlear nucleus for neural hearing loss.
Indications
Notes
Verified as a real current MED-EL hearing solution. The MED-EL site presents SYNCHRONY ABI as an auditory brainstem implant option for neural hearing loss. Exact market-by-market regulatory footprint was not fully verified in this pass.
Evidence & Sources
1 structured sourcescompany
Supports: canonicalName, aliases, company, programType, modality, mechanism, indications, stage...
IDs: SYNCHRONY ABI, ABI
Data Checks
regional-regulatory-footprint-needs-verification
Related Programs
Apple AirPods Pro Hearing Health Features
Company: Apple · Hearing Aid/Software · Marketed
Nuance Audio Hearing Aid Software
Company: EssilorLuxottica · Hearing Aid/Software · Marketed
Cochlear Nucleus Nexa System
Company: Cochlear · Cochlear/Auditory Implant · Marketed
Envoy Medical Acclaim Cochlear Implant
Company: Envoy Medical · Cochlear/Auditory Implant · Phase 2/3
MED-EL SYNCHRONY Cochlear Implant System
Company: MED-EL · Cochlear/Auditory Implant · Marketed
Phonak Audéo Sphere Infinio
Company: Phonak · Hearing Aid/Software · Marketed